Dr. Carter is currently a board certified faculty neurologist and sleep medicine physician at the Clinical Center for Sleep and Breathing Disorders of Clements University Hospital and Program Director of the UT Southwestern Sleep Medicine Fellowship Program. He was Chief of the Neurology and Sleep Medicine Section of the VA North Texas Health Care System in Dallas until August 30, 2009. At the VAMC he spent 25 years involved in basic and clinical research. After finishing his PhD dissertation studies in monoamine metabolism in the neostriatum (Carter 1985), he developed extensive experience in epilepsy, stroke, and clinical pharmacology. In the field of epilepsy, his research has included animal models of epileptogenesis (Carter & Warner, 1987, 1988, 1989) and human studies in epilepsy and antiepileptic drugs (Mattson, et.al. 1992 & 1996, Privitera, et.al.,1996). He has also served as principal investigator in a study of acute pharmacological intervention in new strokes (1995) and was a co-investigator in the NIH-sponsored ACE trial of aspirin and carotid endarterectomy, as well as, a NIAAA study of alcoholism. In 2014 Dr. Carter obtained ACGME approval for a sleep medicine fellowship program that now involves Clements University Hospital's Clinical Center for Sleep and Breathing, Children's Health's Sleep Disorders Center, and the VA North Texas Health Care Center's Sleep Center in a program that trains three clinical fellows per year. Dr. Carter has published his work in home testing for sleep apnea, as well as, an editorial and article on management of obstructive sleep apnea and sleep fellowship training of psychiatrists, plus book chapters on caffeine and sleep disorders and delayed sleep wake phase disorders. Dr. Carter has two additional book chapters coming out in late 2020 regarding obstructive sleep apnea and insomnia in pregnancy. He remains interested in research on the management of restless leg syndrome and REM sleep behavior disorder.
- Medical School
- West Virginia University School of Medicine (1975)
- West Virginia University School of Medicine (1979), Neurology
- West Virginia University School of Medicine (1981), Neuropharmacology
- Graduate School
- West Virginia University School of Medicine (1985), Pharmacology
- Pharmacological management of REM parasomnias
- Subspecialty Training in Sleep Medicine for Psychiatrists
- Gregory Carter, Imran S Khawaja, and Erik St. Louis Psychiatr Ann 2018 48 11 520-523
- Screening for Improvement of Health Outcomes in Asymptomatic Obstructive Sleep Apnea.
- Carter GS JAMA Neurol 2017 Jan
- Acute and emergent events in sleep disorders.
- Carter GS Arch. Neurol. 2012 Jul 69 7 936
- New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine.
- Rowan AJ, Ramsay RE, Collins JF, Pryor F, Boardman KD, Uthman BM, Spitz M, Frederick T, Towne A, Carter GS, Marks W, Felicetta J, Tomyanovich ML Neurology 2005 Jun 64 11 1868-73
- Validity of a portable cardio-respiratory system to collect data in the home environment in patients with obstructive sleep apnea
- Carter GS, Coyle MA, and Mendelson WB Sleep.Hypn 2004 6 2 74-81
- A comparison of valproate with carbamazepine for the treatment of partial seizures and secondarily generalized tonic-clonic seizures in adults.
- Mattson RH, Cramer JA, Collins JF, McCutchen CB, Mamdani MB, Davenport J, Lubozynski MF, Ramsey RE, Carter GS, Rowan AJ, Shin C, Browne TR, Ebersole JS, Treiman DM, Warner JJ, Smith DB, Fish SL, Rubino FA, Salinsky M, Scheyer RD, Wilder FJ New England Journal of Medicine 1992 327 765-771
- Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomized controlled trial.
- Taylor DW, Barnett HJM, Haynes RB, Ferguson GG, Sackett DL, Thorpe KE, Simard D, Silver FL, Hachinski V, Clagett GP, Barnes R, Spence JD for the ASA and Carotid Endarterectomy (ACE) Trial Collaborators Lancet 1999 353 2179-2184
- Effect of valproate on cognitive functioning.
- Prevey ML, Delaney RC, Cramer JA, Cattanach L, Collins JF, Mattson RH for the Department of Veterans Affairs Epilepsy Cooperative Study 264 Group Archives of Neurology 1996 53 1008-1016
- Topiramate placebo-controlled dose ranging trial in refractory partial epilepsy using 600,800, 1000 mg daily dosages.
- Privitera M, Fincham R, Penry J, Reife R, Kramer L, Pledger G, Karim R and the Topiramate YE Study Group Neurology 1996 46 1678-1683
- Test-retest comparability and control subject data for the Rey-Auditory verbal learning test and Rey-Osterreith/Taylor complex figures.
- Delaney RC, Prevey ML, Cramer JA, Mattson RH and the VA Epilepsy Cooperative Study #264 Group Archives of Clinical Neuropsychology 1992 7 1-6
Insomnia and Caffeine. In Comorbid Sleep and Psychiatric Disorders: A Clinical Casebook
Gregory S Carter and Hisham Hamdan (2019). Cham, Switzerland, Springer
Delayed Sleep-Wake Phase Disorder. In Circadian Rhythm Sleep-Wake Disorders
Gregory S Carter and R. Robert Auger (2020). New York, Springer
Honors & Awards
- President, Southern Sleep Society
- American Medical Association (1998)
- Southern Sleep Society (1998)
- American Association of Sleep Medicine (1996)
- American Association of Electrodiagnostic Medicine (1993)
- American Heart Association Stroke Council (1993)
- Dallas County Medical Society (1985)
- Texas Medical Association (1985)
- Texas Neurological Society (1985)
- American Epilepsy Society (1984)
- American Academy of Neurology (1980)
- American Clinical Neurophysiology Society (Fellow) (1980-2002)